tradmap

INFU InfuSystem Holdings, Inc

$9.40 +7.43%

Healthcare · Surgical & Medical Instruments & Apparatus

InfuSystem Holdings, Inc (INFU) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $190 million. Shares last traded at $9.40, 14.6% below their 52-week high. Over the past year the stock is up 52.4%. INFU trades at a price-to-earnings ratio of 28.63, in line with the Surgical & Medical Instruments & Apparatus median of 28.73. Net profit margin is 4.6%, above the peer median of -7.6%. Revenue grew 6.4% year over year.

Market Cap
$190M
Shares Out
20.2M
EPS (TTM)
$0.37
P/E Ratio
25.41
P/S Ratio
1.32
P/B Ratio
3.23
Dividend / Share
Dividend Yield
52-Week High
$11.01
52-Week Low
$5.39
Volume
11,896
Avg Vol (3m)
8,331.365

Performance

1W
+3.98%
1M
-2.99%
3M
-1.05%
6M
+0.97%
YTD
+11.77%
1Y
+52.35%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
54.25
SMA (50)
$9.50
SMA (200)
$9.35
Price vs SMA50
-1.05%
Price vs SMA200
+0.52%
ATR (14)
$0.41

Financials

Revenue
$143M
Net Income
$7M
Gross Margin
56.0%
Operating Margin
8.3%
Net Margin
4.6%
Return on Equity
11.3%
Return on Assets
6.7%
Current Ratio
2.14
Debt / Equity
0.33
Revenue Growth (YoY)
+6.4%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $0.05 2026-05-08
FY 2025 $0.31 2026-02-27
Q3 2025 $0.22 2025-11-04
Q2 2025 $0.11 2025-08-05
Q1 2026 $-0.01 2026-05-08
FY 2025 $0.11 2026-02-27

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

INFU vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/E vs peers
28.63 / 28.73 med
-0% discount
P/S vs peers
1.32 / 2.52 med
-47% discount
Net margin vs peers
4.6% / -7.6% med
above median
1–14 of 14
SYKStryker Corporation$118.1B36.384.7012.9%+2.28%
MMM3M$83.9B25.823.3613.0%+1.10%
BSXBoston Scientific$67.3B23.273.3514.4%+0.64%
BDXBecton Dickinson$39.7B23.641.827.7%+1.62%
MDLNMedline Inc.$29.4B-1.47%
DXCMDexCom$28.0B33.436.0017.9%+1.69%
RMDResMed$27.4B19.535.3227.2%+1.24%
WSTWest Pharmaceutical Services$23.2B46.927.5416.1%+1.35%
SOLVSolventum$13.1B+1.21%
PENPenumbra Inc$12.5B70.188.8812.7%+0.28%
GMEDGlobus Medical Inc$10.8B19.993.6618.3%+5.00%
BAXBaxter International$10.3B-10.740.91-8.5%+2.58%
PODDInsulet Corporation$10.1B40.843.739.1%+1.51%
GKOSGlaukos Corp$7.7B-40.9215.13-37.0%+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.